File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Analisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto): Evaluation of the Health Technology Assessment Process of the Financial Protection System for High-Cost Diagnoses and Treatments in Chile (Ricarte Soto Law)

TitleAnalisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto): Evaluation of the Health Technology Assessment Process of the Financial Protection System for High-Cost Diagnoses and Treatments in Chile (Ricarte Soto Law)
Authors
Keywordshealth benefit plans
health policy
health technology assessment
high-costs drugs
Ley Ricarte Soto
rare diseases
Issue Date2022
Citation
Value in Health Regional Issues, 2022, v. 32, p. 95-101 How to Cite?
AbstractObjectives: In Chile, Ricarte Soto Law defines a financial protection system for high-cost health technologies through a process of prioritization and evaluation of health technologies (ETESA). This study aims to evaluate the ETESA process in terms of its technical content and its coherence with the Chilean regulatory framework. Methodology: This is a documentary review of 34 reports prepared by the Ministry of Health. A data extraction matrix was applied to evaluate the elements in content and process. The analysis evaluated technical errors, process inconsistencies, and disagreements in interpreting results. Results: From 98 technologies, 59 were considered favorable, and 25 received coverage. A total of 20 inconsistencies were identified in the evaluation process, and 39 disagreements were documented on interpreting the results and technical errors. In the prioritization stage, we identified controversies in 44 technologies. Conclusion: The ETESA process of the Ricarte Soto Law is generally consistent with the regulations. Nevertheless, weaknesses persist in both technical and procedural terms. It is expected that the regulatory entity can use these results to implement the necessary improvements
Persistent Identifierhttp://hdl.handle.net/10722/356276
ISSN
2023 Impact Factor: 1.4
2023 SCImago Journal Rankings: 0.525
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorArmijo, Nicolás-
dc.contributor.authorEspinoza, Manuel-
dc.contributor.authorZamorano, Paula-
dc.contributor.authorLahoz, Daniela-
dc.contributor.authorYañez, Tamara-
dc.contributor.authorBalmaceda, Carlos-
dc.date.accessioned2025-05-27T07:21:57Z-
dc.date.available2025-05-27T07:21:57Z-
dc.date.issued2022-
dc.identifier.citationValue in Health Regional Issues, 2022, v. 32, p. 95-101-
dc.identifier.issn2212-1099-
dc.identifier.urihttp://hdl.handle.net/10722/356276-
dc.description.abstractObjectives: In Chile, Ricarte Soto Law defines a financial protection system for high-cost health technologies through a process of prioritization and evaluation of health technologies (ETESA). This study aims to evaluate the ETESA process in terms of its technical content and its coherence with the Chilean regulatory framework. Methodology: This is a documentary review of 34 reports prepared by the Ministry of Health. A data extraction matrix was applied to evaluate the elements in content and process. The analysis evaluated technical errors, process inconsistencies, and disagreements in interpreting results. Results: From 98 technologies, 59 were considered favorable, and 25 received coverage. A total of 20 inconsistencies were identified in the evaluation process, and 39 disagreements were documented on interpreting the results and technical errors. In the prioritization stage, we identified controversies in 44 technologies. Conclusion: The ETESA process of the Ricarte Soto Law is generally consistent with the regulations. Nevertheless, weaknesses persist in both technical and procedural terms. It is expected that the regulatory entity can use these results to implement the necessary improvements-
dc.languageeng-
dc.relation.ispartofValue in Health Regional Issues-
dc.subjecthealth benefit plans-
dc.subjecthealth policy-
dc.subjecthealth technology assessment-
dc.subjecthigh-costs drugs-
dc.subjectLey Ricarte Soto-
dc.subjectrare diseases-
dc.titleAnalisis del proceso de Evaluación de Tecnologías Sanitarias del Sistema de Protección Financiera Para Diagnósticos y Tratamientos de Alto Costo en Chile (Ley Ricarte Soto): Evaluation of the Health Technology Assessment Process of the Financial Protection System for High-Cost Diagnoses and Treatments in Chile (Ricarte Soto Law)-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.vhri.2022.08.001-
dc.identifier.pmid36166949-
dc.identifier.scopuseid_2-s2.0-85141889752-
dc.identifier.volume32-
dc.identifier.spage95-
dc.identifier.epage101-
dc.identifier.eissn2212-1102-
dc.identifier.isiWOS:000864650500002-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats